How can doctors talk about the net benefits of COVID shots if they won’t acknowledge the worst risk? On the Friday after ...

We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

Methanol is an ideal feedstock for bio-manufacturing. Converting it into lactate, a monomer for biodegradable plastic, offers ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

We came across a bullish thesis on CureVac N.V. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...

Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

C&EN networking event in New York City. Please join us if you’re in town! Here’s a link to the invitation. Questions? Comments? Tips? Let us know. Email Michael McCoy, C&EN’s executive editor for ...

Ribosomes don’t just make proteins—they can sense when something’s wrong. When they collide, they send out stress signals ...